Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03018678 · ClinicalTrials.gov registry record
Screening Protocol for a Gene Therapy Trial in Subjects With Homozygous Familial Hypercholesterolemia
A clinical trial of Hypercholesterolemia, Familial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 21
- Enrollment target
- 1
- Study location
NCT03018678: Completed study of Hypercholesterolemia, Familial, sponsored by University of Pennsylvania.
NCT03018678 is a study of Hypercholesterolemia, Familial that has completed, run by University of Pennsylvania. The registered enrollment target is 21 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03018678, a study of Hypercholesterolemia, Familial, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this protocol is to identify and screen potential candidates for future enrollment in a gene therapy clinical trial for HoFH.
Primary Outcome
identification of genetic, confirmation of FH
Conditions Studied
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2016-03 |
| Est. Completion | 2019-12-03 |
What the finished NCT03018678 record still lists
NCT03018678 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 21 participants, a relatively small participant target.
The record links to 1 condition, with Hypercholesterolemia, Familial appearing as the primary indexed condition, and to 0 interventions.
NCT03018678 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03018678 about?
NCT03018678 is a clinical study titled "Screening Protocol for a Gene Therapy Trial in Subjects With Homozygous Familial Hypercholesterolemia". The purpose of this protocol is to identify and screen potential candidates for future enrollment in a gene therapy clinical trial for HoFH.
What is the current status of trial NCT03018678?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2016-03. Estimated completion is 2019-12-03.
What conditions does trial NCT03018678 study?
This clinical trial studies the following conditions: Hypercholesterolemia, Familial.
Who is sponsoring clinical trial NCT03018678?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03018678 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypercholesterolemia, Familial
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia